Some 60 industry clusters located in all nine of Austria’s federal provinces
encompass 7,000 companies and 825,000 employees, enhancing Austria’s strength in innovation. These cluster players feature a high level of internationality and a high research ratio averaging 7.5 percent. Specialized companies, from SMEs and spin-offs to international R&D headquarters, cooperate intensively with each other as well as with research institutes and talented scientists.
Vienna not only offers the best quality of life around the world, but has also established itself as an international location for life sciences. About 380 companies in this sector operate mainly in the fields of biotechnology, pharmaceuticals and medical technology, including well-known multinationals such as Baxalta, Boehringer Ingelheim, Novartis and Ottobock. They generated revenue surpassing EUR 9 billion in 2014, employing a workforce of 21,000 people. They are complemented by 14,000 highly qualified specialized staff at 25 research facilities in the Austrian capital city.
LISAvienna supports innovative companies to develop new products, services and processes and launch them on the marketplace. The platform networks companies, linking them with development partners and key customers.
Life Sciences Tirol
60 innovative companies boasting more than 23,000 qualified employees and offering product and service solutions in life sciences are linked via the Life Sciences Cluster Tirol in the west of Austria. Entrepreneurial success is ensured based on the good cooperation with international universities such as the Munich University of Technology and non-university research institutes, Oncotyrol, the Competence Center for Personalized Cancer Medicine and Bioindustry Park Canavese.
The focus in Styria is on “white biotechnology”. Some 80 partner organizations of the human technology cluster focus on three areas of competence: pharmaceutical process and production technologies, biomedical sensor technologies and biomechanics as well as biobanking and biomarker technologies. The partners of Human.Technology.Styria have won international recognition, including the “International Innovation Prize 2014” for the “Enzyme Google”. A patent application was filed for the “Catalophor system” developed by acib as described in the scientific journal “Nature Communications”.
This Lower Austrian hotspot for medical biotechnology not only carries out cancer research but groundbreaking research on blood purification procedures, artificial joints and cartilage and the healing of chronic injuries. The focus of Technopol Krems is on biomedicine (tissue engineering, cell therapies, extracorporeal blood purification) and health sciences.
Medical Technology Cluster Upper Austria
The Medical Technology Cluster Upper Austria, a network for this industry, supports medical and health care technology companies. The cluster has 217 members with 37,500 employees.